1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow T-Vec: new trials by email Literature Review of T-Vec trials Research Report on T-Vec
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pembrolizumab With Talimogene Laherparepvec or Placebo in Unresected Melanoma Talimogene Laherparepvec, Pembrolizumab, Placebo - Melanoma | Phase 3 | Terminated | Amgen | 713 | 2014-12-08 | 2022-11-14 |
Melanoma (1)
Amgen (1)
Australia (1) · Austria (1) · Belgium (1) · Canada (1) · Czechia (1) · Finland (1) · France (1) · Germany (1) · Greece (1) · Hungary (1) · Italy (1) · Netherlands (1) · Poland (1) · Portugal (1) · Russia (1)
2014 (1)